Avita Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $760k | 71k | 10.72 |
| 2024-06-30 | $562k | 71k | 7.92 |
| 2024-03-31 | $1.1M | 67k | 16.03 |
| 2023-12-31 | $947k | 69k | 13.72 |
| 2023-09-30 | $1.0M | 69k | 14.61 |
| 2023-06-30 | $1.1M | 68k | 17.01 |
| 2023-03-31 | $141k | 10k | 13.97 |
| 2022-12-31 | $66k | 10k | 6.60 |
| 2022-09-30 | $53k | 10k | 5.27 |
| 2022-06-30 | $48k | 10k | 4.77 |
| 2022-03-31 | $537k | 63k | 8.49 |
| 2021-12-31 | $744k | 62k | 11.98 |
| 2021-09-30 | $1.1M | 62k | 17.72 |
| 2021-06-30 | $1.2M | 61k | 20.53 |